Patientsville.com

Do You Have a Question about Your Health?

We will help You understand Your condition and Feel better! Ask Our Health Experts!

Private, Confidential and Discreet Type your question here

 letters left

MEMANTINE Safety Reports

Total MEMANTINE reports: 154.
MEMANTINE FDA safety alerts: No.
Reported deaths: 24    Reported hospitalizations: 103.
Take MEMANTINE Side Effects Survey or Share Your MEMANTINE Story. Read More Here.

Showing 1-75 of 154 Next >

Health Professional from ITALY reported MEMANTINE problem on Sept 14, 2006. Female patient, 91 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with HALOPERIDOLE, ACEIL SALICILATE OF LYSINE, ENALAPRIL MALEATE. Patient was hospitalized and became disabled. Patient recovered.

MEMANTINE problem was reported by a Consumer or non-health professional from JAPAN on Sept 11, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alanine aminotransferase increased, albumin globulin ratio decreased, anorexia, aspartate aminotransferase increased, blood calcium decreased, blood chloride decreased, blood cholinesterase decreased, blood creatine phosphokinase increased. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE. Patient was hospitalized. Patient died on 03/29/2006.

Consumer or non-health professional from CANADA reported MEMANTINE problem on Sept 07, 2006. Male patient, 77 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: fall. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with DILANTIN. Patient was hospitalized. Patient recovered.

MEMANTINE problem was reported by a Health Professional from SPAIN on Sept 01, 2006. Male patient, 66 years of age, weighting 136.7 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, pancreatitis. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with RISPERDAL, LORAZEPAM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported MEMANTINE problem on Sept 20, 2006. Male patient, 63 years of age, weighting 159.8 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: retinal detachment, vitreous haemorrhage. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with AMLODIPINE BESYLATE, TELMISARTAN, CARBAZOCHROME SULFONATE. Patient was hospitalized. Patient recovered.

MEMANTINE problem was reported by a Health Professional from BELGIUM on Sept 26, 2006. Female patient, 86 years of age, weighting 180.8 lb, was diagnosed with apathy and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cerebral atrophy, leukoaraiosis, psychomotor hyperactivity. MEMANTINE dosage: 5 MG QD PO. During the same period patient was treated with ATORVASTATIN, ASPIRIN, TRAZODONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported MEMANTINE problem on Sept 12, 2006. Female patient, 60 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: disease recurrence, hypertensive crisis. MEMANTINE dosage: unknown. During the same period patient was treated with PALLADONE, ARCOXIA, LYRICA, CLOPIDOGREL BISULPHATE, TORSEMIDE, ENALAPRIL MALEATE, CORVATON, NEXIUM. Patient recovered.

MEMANTINE problem was reported by a Health Professional from JAPAN on Sept 22, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: anaemia, blood calcium decreased, blood cholinesterase decreased, blood glucose increased, blood potassium decreased, blood sodium decreased, cough, depressed level of consciousness, diffuse large b-cell lymphoma stage iv. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient died on 03/29/2006.

Consumer or non-health professional from SWEDEN reported MEMANTINE problem on Sept 05, 2006. Female patient, 83 years of age, weighting 154.3 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, aggression, anxiety, arteriosclerosis, bladder pain, blood pressure immeasurable, bowel sounds abnormal, cardiovascular disorder, cerebral atrophy. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with BEHEPAN, FOLACIN, KATAIPOS D, OXASCAND, HEMINEURIN, ZOPLIKON. Patient died on 11/14/2004.

MEMANTINE problem was reported by a Health Professional from FRANCE on Sept 18, 2006. Male patient, 73 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: atrial flutter, blood sodium increased, c-reactive protein increased, consciousness fluctuating, fall, overdose, somnolence. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with HEPARIN CALCIUM, ARICEPT, SECTRAL, PERINDOPRIL ERBUMINE, LASIX, IKOREL, KARVEA HCT, ASPIRIN. Patient was hospitalized. Patient recovered.

Health Professional from BELGIUM reported MEMANTINE problem on Sept 04, 2006. Male patient, 75 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, blood uric acid decreased, cognitive disorder, depressed level of consciousness, diabetes mellitus inadequate control, disorientation, disturbance in social behaviour, dizziness, glycosylated haemoglobin increased. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with LACRYSTAT, PRANOX, ACETYLSALICYLIC ACID SRT, PERSANTINE, CITALOPRAM HYDROBROMIDE, TRAZOLAN, PANTOPRAZOLE, DIAMICRON. Patient was hospitalized. Patient recovered.

MEMANTINE problem was reported by a Health Professional from FRANCE on Sept 22, 2006. Male patient, 77 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: prostatic adenoma, urinary incontinence, urinary tract infection. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with EXELON. Patient recovered.

Health Professional from GERMANY reported MEMANTINE problem on Oct 11, 2006. Male patient, 66 years of age, weighting 136.7 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, pancreatitis. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with RISPERDAL, LORAZEPAM. Patient was hospitalized. Patient recovered.

MEMANTINE problem was reported by a Physician from UNITED STATES on Oct 18, 2006. Male patient, weighting 140.0 lb, was diagnosed with dyskinesia, dystonia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, post concussion syndrome, rash erythematous, rash papular, rash pustular, stevens-johnson syndrome. MEMANTINE dosage: unknown. During the same period patient was treated with AMANTADINE. Patient recovered.

Physician from UNITED STATES reported MEMANTINE problem on Oct 16, 2006. Female patient, 86 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, blood calcium decreased, blood chloride increased, blood glucose increased, blood potassium decreased, blood sodium increased, blood urea increased, diarrhoea haemorrhagic, diverticulitis. MEMANTINE dosage: 28 MG QD PO. During the same period patient was treated with IMODIUM. Patient was hospitalized. Patient recovered.

MEMANTINE problem was reported by a Health Professional from AUSTRALIA on Feb 06, 2003. Male patient, 79 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: pneumonia. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with FLIXOTIDE, ATROVENT, CEPHALEXIN, PREDNISONE, RISPERDAL, PANTOPRAZOLE, VENTOLIN, MORPHINE. Patient was hospitalized. Patient died on 12/24/2002.

Physician from UNITED STATES reported MEMANTINE problem on Oct 17, 2006. Female patient, 88 years of age, weighting 114.0 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase decreased, anaemia, asthenia, blood amylase increased, brain natriuretic peptide increased, cardiac failure congestive, carotid artery atheroma, coronary artery insufficiency, dizziness. MEMANTINE dosage: 28 MG QD PO. During the same period patient was treated with DONEPEZIL HYDROCHLORIDE, FOLIC ACID, MIRTAZAPINE, RISEDRONATE, DOCUSATE, RANITIDINE, TRIMETHOPRIM, DARVOCET. Patient was hospitalized. Patient recovered.

MEMANTINE problem was reported by a Health Professional from CANADA on Aug 24, 2006. Female patient, 91 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction, pancreatitis. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with DIDROCAL, CALCIUM, ACCUPRIL, NORVASC, HYDROCHLOROTHIAZIDE, PLAVIX, ARTHROTEC, TYLENOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ITALY reported MEMANTINE problem on Oct 17, 2006. Female patient, 75 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: bradykinesia, hallucination, visual, muscle rigidity. MEMANTINE dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, BISPHOSPHONATE, DONEPEZIL, PAROXETINE, TRAZODONE, FOLIC ACID, VITAMIN E. Patient recovered.

MEMANTINE problem was reported by a Health Professional from GERMANY on Oct 20, 2006. Male patient, 79 years of age, was diagnosed with dementia, agitation, sleep disorder and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: agitation, fall, pleurothotonus, restlessness, sleep disorder. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with REMINYL, DOMINAL, GLUCOBAY, PRAVASTATIN, METOPROLOL TARTRATE. Patient was hospitalized. Patient recovered.

Health Professional from ITALY reported MEMANTINE problem on Oct 24, 2006. Female patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, ophthalmoplegia, strabismus. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with VERAPAMIL, CARDIRENE, CENTRUM, B VITAMINE, EPHYNAL, EPARGRISEOVIT. Patient recovered.

MEMANTINE problem was reported by a Health Professional from FRANCE on Oct 16, 2006. Female patient, 82 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: disinhibition, hallucinations, mixed, renal failure. MEMANTINE dosage: unknown. During the same period patient was treated with EXELON. Patient recovered.

Health Professional from FRANCE reported MEMANTINE problem on Oct 25, 2006. Male patient was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: escherichia infection, prostatitis, sepsis. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with IKOREL, ATENOL, PRAVASTATIN, EQUANIL. Patient recovered.

MEMANTINE problem was reported by a Health Professional from ITALY on Oct 18, 2006. Female patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, extraocular muscle paresis, fibrosis, gamma-glutamyltransferase increased, strabismus, ultrasound doppler abnormal. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with VERAPAMIL, CARDIRENE, CENTRUM, B VITAMINE, EPHYNAL, EPARGRISEOVIT. Patient recovered.

Health Professional from JAPAN reported MEMANTINE problem on Oct 27, 2006. Male patient, 78 years of age, weighting 114.6 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: anorexia, dehydration, jaundice cholestatic, malnutrition, metastases to liver, metastases to lymph nodes, pancreatic carcinoma, weight decreased. MEMANTINE dosage: unknown. During the same period patient was treated with ASPIRIN, AMLODIPINE BESYLATE, VALSARTAN, TERBINAFINE, DEXAMETHASONE. Patient was hospitalized. Patient died on 04/22/2006.

MEMANTINE problem was reported by a Physician from UNITED STATES on Oct 25, 2006. Female patient, weighting 98.00 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, cerebrovascular accident, hypersomnia, hypertension, hypothyroidism, oral intake reduced, skin laceration, wound. MEMANTINE dosage: 28 MG QD. During the same period patient was treated with DONEPEZIL, NORVASC, FOLIC ACID. Patient was hospitalized. Patient died on 03/04/2006.

Consumer or non-health professional from SPAIN reported MEMANTINE problem on Nov 01, 2006. Male patient, 66 years of age, weighting 136.7 lb, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, pancreatitis. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with RISPERDAL, LORAZEPAM. Patient was hospitalized. Patient recovered.

MEMANTINE problem was reported by a Health Professional from JAPAN on Oct 31, 2006. Male patient, 92 years of age, weighting 128.1 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cerebral infarction, depressed level of consciousness, fall, gait disturbance, restlessness, somnolence. MEMANTINE dosage: unknown. During the same period patient was treated with PITAVASTATIN CALCIUM, NICERGOLINE, DENOPAMINE, DIGESTIVE ENZYME PREPARATIONS, FAMOTIDINE, CITICOLINE, CYANOCOBALAMIN, THIAMINE DISULFIDE NITRATE. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported MEMANTINE problem on Oct 26, 2006. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: hepatic cirrhosis, hepatic neoplasm malignant. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with PERINDOPRIL ERBUMINE, POTASSIUM CHLORIDE, CACIT D. Patient was hospitalized. Patient died on 04/02/2004.

MEMANTINE problem was reported by a Health Professional from ITALY on Oct 26, 2006. Female patient, 91 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with HALOPERIDOLE, ACEIL SALICILIATE OF LYSINE, ENALAPRIL MALEATE, ACETIL SALICILIC ACID, NITRENDIPINA, DONEPEZIL. Patient was hospitalized and became disabled. Patient recovered.

Consumer or non-health professional from SWITZERLAND reported MEMANTINE problem on Nov 03, 2006. Female patient, 58 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: convulsion, grand mal convulsion, hypochloraemia, hypokalaemia, inappropriate antidiuretic hormone secretion, loss of consciousness. MEMANTINE dosage: 15 MG QD PO. Patient was hospitalized. Patient recovered.

MEMANTINE problem was reported by a Consumer or non-health professional from SWEDEN on Oct 30, 2006. Female patient, 83 years of age, weighting 154.3 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: aggression, arteriosclerosis, cardiovascular disorder, fall, gastric disorder, hallucination, nephrosclerosis, oral intake reduced, pulmonary congestion. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with BEHEPAN, FOLACIN, KATAIPOS D, OXASCAND, HEMINEURIN, ZOPLIKON. Patient died on 11/14/2004.

Physician from UNITED STATES reported MEMANTINE problem on Oct 31, 2006. Female patient, 79 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. MEMANTINE dosage: unknown. During the same period patient was treated with RISPERIDONE, RIVASTIGMINE. Patient died.

MEMANTINE problem was reported by a Physician from UNITED STATES on Oct 31, 2006. Female patient, 89 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: completed suicide, intentional overdose. MEMANTINE dosage: unknown. During the same period patient was treated with VERAPAMIL, DONEPEZIL. Patient died.

Health Professional from BELGIUM reported MEMANTINE problem on Nov 14, 2006. Female patient, 86 years of age, weighting 180.8 lb, was diagnosed with apathy and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, leukoaraiosis, psychomotor hyperactivity. MEMANTINE dosage: 5 MG QD PO. During the same period patient was treated with ATORVASTATIN CALCIUM, ASPIRIN, TRAZODONE. Patient was hospitalized. Patient recovered.

MEMANTINE problem was reported by a Health Professional from SPAIN on Nov 01, 2006. Male patient, 66 years of age, weighting 136.7 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, pancreatitis. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with RISPERDAL, LORAZEPAM. Patient was hospitalized. Patient recovered.

Health Professional from DENMARK reported MEMANTINE problem on Nov 21, 2006. Female patient, 76 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: delirium. MEMANTINE dosage: 10 MG BID PO. Patient recovered.

MEMANTINE problem was reported by a Health Professional from GERMANY on Nov 17, 2006. Female patient, 17 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: electrocardiogram change, hypokinesia, vomiting. MEMANTINE dosage: 100 MG QD PO. During the same period patient was treated with ETHANOL, VERAPAMIL. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported MEMANTINE problem on Dec 02, 2006. Female patient, 81 years of age, was diagnosed with dementia alzheimer's type, arteritis coronary and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: syncope. MEMANTINE dosage: unknown. During the same period patient was treated with INFLUENZA VACCINE, EXELON, CORVASAL. Patient died.

MEMANTINE problem was reported by a Health Professional from FRANCE on Nov 14, 2006. Female patient, 70 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased. MEMANTINE dosage: unknown. During the same period patient was treated with GALANTAMINE HYDROBROMIDE. Patient recovered.

Health Professional from FRANCE reported MEMANTINE problem on Nov 14, 2006. Male patient, 84 years of age, weighting 136.7 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: bedridden, dysstasia, gait disturbance, somnolence. MEMANTINE dosage: 5 MG QD PO. During the same period patient was treated with DILTIAZEM HYDROCHLORIDE, ASPIRIN, CITALOPRAM HYDROBROMIDE, ATARAX. Patient recovered.

MEMANTINE problem was reported by a Health Professional from BELGIUM on Nov 27, 2006. Male patient, 75 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, agitation, blood glucose increased, cholecystitis acute, depressed level of consciousness, gait disturbance, glabellar reflex abnormal, glycosylated haemoglobin increased. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with LACRYSTAT, PRANOX, ACETYLSALICYLIC ACID SRT, PERSANTINE, CITALOPRAM HYDROBROMIDE, TRAZOLAM, PANTOZOL, DIAMICRON. Patient was hospitalized. Patient recovered.

Health Professional from ITALY reported MEMANTINE problem on Nov 10, 2006. Female patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cerebral ventricle dilatation, diplopia, disorientation, gamma-glutamyltransferase increased, mydriasis, ophthalmoplegia, strabismus. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with VERAPAMIL, CARDIRENE, CENTRUM, B VITAMINE, EPHYNAL, EPARGRISEOVIT. Patient recovered.

MEMANTINE problem was reported by a Health Professional from FRANCE on Nov 21, 2006. Male patient, 91 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: dyspnoea at rest, epstein-barr virus test positive, haemolytic anaemia, mycoplasma infection. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with PAROXETINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported MEMANTINE problem on Nov 29, 2006. Female patient was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with GALANTAMINE HYDROBROMIDE, EQUANIL. Patient recovered.

MEMANTINE problem was reported by a Health Professional from ITALY on Nov 24, 2006. Female patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cerebral ventricle dilatation, computerised tomogram abnormal, dementia alzheimer's type, diplopia, disease progression, disorientation, eye movement disorder. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with VERAPAMIL, CARDIRENE, CENTRUM, B VITAMINE, EPHYNAL, EPARGRISEOVIT. Patient recovered.

Health Professional from JAPAN reported MEMANTINE problem on Dec 01, 2006. Male patient, 78 years of age, weighting 114.6 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: anorexia, dehydration, jaundice cholestatic, malnutrition, metastases to liver, metastases to lymph nodes, pancreatic neoplasm. MEMANTINE dosage: unknown. During the same period patient was treated with ASPIRIN, AMLODIPINE BESYLATE, VALSARTAN. Patient was hospitalized. Patient died on 04/22/2006.

MEMANTINE problem was reported by a Pharmacist from ITALY on Oct 26, 2006. Male patient, 75 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: anal sphincter atony, electrocardiogram st segment abnormal, electroencephalogram abnormal, loss of consciousness, malaise, trismus. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with QUETIAPINE FUMARATE, QUETIAPINE FUMARATE, VALPROIC ACID. Patient recovered.

Health Professional from GERMANY reported MEMANTINE problem on Dec 14, 2006. Female patient was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with GALANTAMINE HYDROBROMIDE, EQUANIL. Patient recovered.

MEMANTINE problem was reported by a Physician from UNITED STATES on Dec 12, 2006. Female patient, 82 years of age, weighting 98.00 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: amnesia, arteriosclerosis, bedridden, blood pressure diastolic decreased, blood pressure inadequately controlled, cerebrovascular accident, fluid intake reduced, hypertension. MEMANTINE dosage: 28 MG QD. During the same period patient was treated with DONEPEZIL, NORVASC, FOLIC ACID. Patient was hospitalized. Patient died on 03/04/2006.

Health Professional from JAPAN reported MEMANTINE problem on Dec 15, 2006. Female patient, 77 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: fall, immobile, pyrexia, tremor. MEMANTINE dosage: unknown. During the same period patient was treated with ASPIRIN, PROPIVERINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

MEMANTINE problem was reported by a Health Professional from FRANCE on Dec 14, 2006. Female patient was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with GALANTAMINE HYDROBROMIDE, EQUANIL. Patient recovered.

Consumer or non-health professional from FRANCE reported MEMANTINE problem on Dec 12, 2006. Female patient, 91 years of age, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: coma, confusional state, respiratory disorder. MEMANTINE dosage: unknown. During the same period patient was treated with POTASSIUM CHLORIDE, FORLAX, SERORAM, DIGOXIN, SINTROM. Patient recovered.

MEMANTINE problem was reported by a Health Professional from UNITED STATES on Dec 20, 2006. Male patient, 85 years of age, weighting 183.0 lb, was diagnosed with cerebral atrophy and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: aortic dilatation, blood urea increased, breath sounds abnormal, cardiac pacemaker insertion, dilatation atrial, fall, feeling abnormal, glomerular filtration rate decreased, haematocrit decreased. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with DONEPEZIL, WARFARIN, SOTALOL HYDROCHLORIDE, GLYBURIDE AND METFORMIN, ACTOS, SIMVASTATIN, TERAZOSIN. Patient was hospitalized. Patient recovered.

Health Professional from GERMANY reported MEMANTINE problem on Apr 02, 2007. Male patient, 88 years of age, weighting 147.5 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arthritis, blood pressure systolic increased, bronchopneumonia, c-reactive protein increased, cough, decreased activity, pyrexia, somnolence. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with AMLODIPINE BESYLATE, TEPRENONE, ASPIRIN, URSODIOL, TERBINAFINE, BETAMETHASONE DIPROPIONATE. Patient was hospitalized. Patient recovered.

MEMANTINE problem was reported by a Consumer or non-health professional from GREECE on June 18, 2007. Female patient, 94 years of age, weighting 110.2 lb, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with SEROQUEL, SALOSPIR, THYROHORMONE. Patient recovered.

Health Professional from IRELAND reported MEMANTINE problem on June 06, 2007. Female patient, 86 years of age, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: antineutrophil cytoplasmic antibody positive, dialysis, renal failure, vasculitis. MEMANTINE dosage: unknown. Patient recovered.

MEMANTINE problem was reported by a Physician from UNITED STATES on June 26, 2007. Female patient, 65 years of age, weighting 119.0 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: balance disorder, ecchymosis, face injury, fall. MEMANTINE dosage: 28 MG QD;PO. During the same period patient was treated with ACETAMINOPHEN, ASPIRIN, ARTHROTEC, TRIAMCINOLONE ACETONIDE, GALANTAMINE HYDROBROMIDE, GLUCOSAMINE CHONDROITIN. Patient recovered.

Health Professional from FRANCE reported MEMANTINE problem on June 26, 2007. Male patient, 61 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: bronchospasm, condition aggravated. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with EXELON, FORADIL, MIFLASONE, STABLON, ASPIRIN, PRAVASTATIN. Patient recovered.

MEMANTINE problem was reported by a Consumer or non-health professional from GERMANY on May 04, 2007. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type, fatigue, social avoidant behaviour and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, blood pressure systolic decreased, cardiogenic shock, chest pain, coronary artery disease, coronary artery occlusion, coronary artery stenosis, dyspnoea. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with DONEPEZIL, RITALIN, DILTIAZEM, METOPROLOL SUCCINATE, SIMVASTATIN, GEMFIBROZIL, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.

Health Professional from GERMANY reported MEMANTINE problem on July 02, 2007. Male patient, 90 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, chest pain, cholecystitis, cholelithiasis, condition aggravated, heart rate increased, pyrexia. MEMANTINE dosage: unknown. During the same period patient was treated with DONEPEZIL, AMBROXOL HYDROCHLORIDE, SENNA LEAF, RANITIDINE HYDROCHLORIDE, TEPRENONE, URSODESOYXCHOLIC ACID, MIDODRINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

MEMANTINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 06, 2007. Male patient, 62 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, cardiac hypertrophy, cerebral atrophy, homicide, poisoning, unresponsive to stimuli. MEMANTINE dosage: 10 MG BID. During the same period patient was treated with DONEPEZIL, CLONAZEPAM, PROPOXYPHENE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE. Patient died.

Health Professional from GERMANY reported MEMANTINE problem on July 09, 2007. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type, fatigue, social avoidant behaviour and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, blood creatine phosphokinase increased, cardiogenic shock, chest pain, coronary artery stenosis, dizziness, dyspnoea, ejection fraction decreased. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with DILTIAZEM, DONEPEZIL, RITALIN, METOPROLOL EXTENDED, SIMVASTATIN, GEMFIBROZIL, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.

MEMANTINE problem was reported by a Health Professional from FRANCE on July 16, 2007. Female patient, 86 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block complete. MEMANTINE dosage: unknown. During the same period patient was treated with GALANTAMINE HYDROBROMIDE. Patient recovered.

Health Professional from GERMANY reported MEMANTINE problem on Nov 14, 2005. Male patient, 78 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: anaemia, blood disorder, chronic lymphocytic leukaemia, condition aggravated, fluid retention, hepatocellular damage, splenomegaly. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with QUETIAPINE FUMARATE, TRAZODONE, LOXAPINE, ASPIRIN, RABEPRAZOLE, TEGRETOL, ACETAMINOPHEN. Patient recovered.

MEMANTINE problem was reported by a Health Professional from JAPAN on July 24, 2007. Male patient, 90 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cholecystitis, cholelithiasis, heart rate increased. MEMANTINE dosage: unknown. During the same period patient was treated with DONEPEZIL, AMBROXOL HYDROCHLORIDE, SENNA LEAF, RANITIDINE HYDROCHLORIDE, TEPRENONE, URSODESOXYCHOLIC ACID. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported MEMANTINE problem on July 19, 2007. Female patient, 75 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: acute prerenal failure, agitation, bacteria urine, blood pressure decreased, body temperature increased, cardiomegaly, dehydration, hypernatraemia. MEMANTINE dosage: unknown. During the same period patient was treated with LIPITOR, ALLERGRA, EXELON, PRILOSEC, CALCIUM CHLORIDE, CENTRIUM SILVER, ASPIRIN, GLYCOLAX. Patient was hospitalized. Patient recovered.

MEMANTINE problem was reported by a Physician from UNITED STATES on July 26, 2007. Male patient, 85 years of age, weighting 183.0 lb, was diagnosed with atrophy and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood pressure increased, blood urea increased, bradycardia, dilatation atrial, dizziness, fall, haematocrit decreased, haemoglobin decreased. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with DONEPEZIL, WARFARIN, SOTALOL HYDROCHLORIDE, GLYBURIDE AND METFORMIN, ACTOS, SIMVASTATIN, TERAZOSIN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported MEMANTINE problem on Aug 07, 2007. Female patient, 75 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: acute prerenal failure, agitation, blood pressure decreased, body temperature increased, cardiomegaly, condition aggravated, dehydration, fall. MEMANTINE dosage: 28 MG QD PO. During the same period patient was treated with LIPITOR, ALLEGRA, EXELON, PRILOSEC, CALCIUM, CENTRUM SILVER, ASPIRIN, GLYCOLAX. Patient was hospitalized. Patient recovered.

MEMANTINE problem was reported by a Health Professional from UNITED KINGDOM on June 22, 2007. Male patient, 78 years of age, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, fall, unresponsive to stimuli. MEMANTINE dosage: unknown. During the same period patient was treated with ASPIRIN, SOTALOL HYDROCHLORIDE, GLICLAZINE, FYBOGEL, SENNA, HYDROXOCOBALAMIN, DONEPEZIL, GALANTAMINE HYDROBROMIDE. Patient was hospitalized. Patient died on 06/30/2007.

Health Professional from UNITED KINGDOM reported MEMANTINE problem on Aug 21, 2007. Male patient, 78 years of age, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, fall, loss of consciousness, pain. MEMANTINE dosage: unknown. During the same period patient was treated with ASPIRIN, SOTALOL HYDROCHLORIDE, GLICLAZINE, FYBOGEL, SENNA, HYDROXOCOBALAMIN, DONEPEZIL, GALANTAMINE HYDROBROMIDE. Patient was hospitalized. Patient died on 06/30/2007.

MEMANTINE problem was reported by a Physician from ARGENTINA on Aug 25, 2007. Female patient, 80 years of age, weighting 160.9 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus inadequate control, diabetic foot. MEMANTINE dosage: 28 MG QD PO. During the same period patient was treated with INSULIN, OLANZAPINE, PAROXETINE, DONEPEZIL, ALPRAZOLAM, OXYBUTYNIN CHLORIDE. Patient was hospitalized. Patient recovered.

Health Professional from GERMANY reported MEMANTINE problem on Aug 23, 2007. Male patient, 70 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, pancreatitis. MEMANTINE dosage: 10 MG BID PO. Patient was hospitalized. Patient recovered.

MEMANTINE problem was reported by a Physician from ARGENTINA on Aug 25, 2007. Female patient, 80 years of age, weighting 160.9 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: dermatitis bullous, diabetes mellitus inadequate control, diabetic foot, localised infection, malaise, varicose vein. MEMANTINE dosage: 28 MG QD PO. During the same period patient was treated with INSULIN, OLANZAPINE, PAROXETINE, DONEPEZIL, ALPRAZOLAM, OXYBUTYNIN CHLORIDE. Patient was hospitalized. Patient recovered.

Physician from ARGENTINA reported MEMANTINE problem on Sept 07, 2007. Male patient, 75 years of age, weighting 140.0 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: anxiety, cardiac arrest, cardiac failure. MEMANTINE dosage: 28 MG QD PO. During the same period patient was treated with DONEPEZIL, EZOPICLONE. Patient died on 09/05/2007.

Showing 1-75 of 154 Next >